Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-29

FDA Approved: TERIFLUNOMIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for teriflunomide from Mylan Pharmaceuticals Inc., indicating an approved update to the product previously approved unde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriflunomide (teriflunomide)

Snippet

SUPPL AP for TERIFLUNOMIDE (TERIFLUNOMIDE)